Literature DB >> 10554081

Different types of antiphospholipid antibodies in AIDS: a comparison with syphilis and the antiphospholipid syndrome.

G F de Larrañaga1, R R Forastiero, L O Carreras, B S Alonso.   

Abstract

Alloimmune antiphospholipid antibodies react with phospholipids and are an epiphenomenon of an infectious disease. Most autoimmune antiphospholipid antibodies recognise phospholipid-protein complexes or proteins, such as beta2 glycoprotein I or prothrombin and are related to the clinical features of the antiphospholipid syndrome. Lupus anticoagulant, anticardiolipin antibodies, antiprothrombin, and anti-beta2 glycoprotein I antibodies were studied in 61 human immunodeficiency virus (HIV) patients, 55 syphilis patients, and 45 selected patients with antiphospholipid syndrome. Lupus anticoagulant was present in 72% of HIV and 81% of antiphospholipid syndrome patients. None of the syphilis patients had lupus anticoagulant. Anticardiolipin antibodies were found at comparable prevalence in the three groups (HIV 67%, syphilis 67%, antiphospholipid syndrome 84%). HIV had more frequently anti-beta2 glycoprotein I (13%) and antiprothrombin (12%) antibodies than syphilis (0 and 4%, respectively), but significantly less than antiphospholipid syndrome (61 and 40%, respectively). Autoimmune antiphospholipid antibodies in HIV without clinical features of antiphospholipid syndrome might be a reflex of the immunological chaos and/or the constant antigenic virus stimulus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10554081     DOI: 10.1016/s0049-3848(99)00059-6

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  11 in total

1.  A summary of the workshop on passive immunization using monoclonal antibodies for HIV/AIDS, held at the National Institute of Allergy and Infectious Diseases, Bethesda, 10 March 2006.

Authors:  Geetha P Bansal
Journal:  Biologicals       Date:  2007-09-21       Impact factor: 1.856

2.  A high-risk laboratory profile of antiphospholipid antibodies and thrombosis is associated with a large number of extra-criteria manifestations in obstetric antiphospholipid syndrome.

Authors:  Sebastián Udry; José Omar Latino; Cristina Belizna; Silvia Perés Wingeyer; Diego Santiago Fernández Romero; Gabriela de Larrañaga
Journal:  Immunol Res       Date:  2019-12       Impact factor: 2.829

Review 3.  The antiphospholipid syndrome and infection.

Authors:  G N Dalekos; K Zachou; C Liaskos
Journal:  Curr Rheumatol Rep       Date:  2001-08       Impact factor: 4.592

4.  What is the best time to assess the antiphospholipid antibodies (aPL) profile to better predict the obstetric outcome in antiphospholipid syndrome (APS) patients?

Authors:  Jose Omar Latino; Sebastián Udry; Silvia Perés Wingeyer; Diego Fernández Romero; Paula Micone; Gabriela de Larrañaga
Journal:  Immunol Res       Date:  2018-10       Impact factor: 2.829

5.  Andes virus antigens are shed in urine of patients with acute hantavirus cardiopulmonary syndrome.

Authors:  Paula Godoy; Delphine Marsac; Elias Stefas; Pablo Ferrer; Nicole D Tischler; Karla Pino; Pablo Ramdohr; Pablo Vial; Pablo D T Valenzuela; Marcela Ferrés; Francisco Veas; Marcelo López-Lastra
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

6.  Prevalence of antiphospholipid and antiplatelet antibodies in human immunodeficiency virus (HIV)-infected Chilean patients.

Authors:  Iván Palomo; Marcelo Alarcón; Cecilia Sepulveda; Jaime Pereira; Ricardo Espinola; Silvia Pierangeli
Journal:  J Clin Lab Anal       Date:  2003       Impact factor: 2.352

7.  Anticardiolipin, anti-beta(2)-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease.

Authors:  S Loizou; S Singh; E Wypkema; R A Asherson
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

8.  Prevalence and isotype distribution of antiphospholipid antibodies in unselected Chilean patients with venous and arterial thrombosis.

Authors:  Iván Palomo; Jaime Pereira; Marcelo Alarcón; Marcela Vásquez; Carmen Pinochet; María T Vélez; Jorge Sandoval; Gloria Icaza; Silvia Pierangeli
Journal:  Clin Rheumatol       Date:  2004-01-31       Impact factor: 2.980

Review 9.  Antiphospholipid antibodies in response to infection.

Authors:  Tadej Avcin; Natasa Toplak
Journal:  Curr Rheumatol Rep       Date:  2007-06       Impact factor: 4.686

10.  HIV-Associated Venous Thromboembolism.

Authors:  Michele Bibas; Gianluigi Biava; Andrea Antinori
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-07-08       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.